{"count": 3, "results": [{"_id": "40713894", "pmid": 40713894, "title": "Copy number amplification of TTPAL promotes cholesterol biosynthesis and esophageal squamous cell carcinoma progression via elevating NSUN2-mediated m5C modification of SREBP2 mRNA.", "journal": "J Exp Clin Cancer Res", "authors": ["Huang S", "Liu Y", "Zhao M", "Wang T", "Mao L", "Wang T", "Guo C", "Huang W", "Peng Z", "Zhang Z", "Jiang R", "Ma X", "Shen N", "Rao J", "Wang X", "Zheng Z", "Chen L"], "date": "2025-07-26T00:00:00Z", "doi": "10.1186/s13046-025-03483-8", "meta_date_publication": "2025 Jul 26", "meta_volume": "44", "meta_issue": "1", "meta_pages": "220", "score": 50254.594, "text_hl": "Moreover, we validate the efficacy of @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ biosynthesis inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@ with high @GENE_TTPAL @GENE_79183 @@@TTPAL@@@ expression. ", "citations": {"NLM": "Huang S, Liu Y, Zhao M, Wang T, Mao L, Wang T, Guo C, Huang W, Peng Z, Zhang Z, Jiang R, Ma X, Shen N, Rao J, Wang X, Zheng Z, Chen L. Copy number amplification of TTPAL promotes cholesterol biosynthesis and esophageal squamous cell carcinoma progression via elevating NSUN2-mediated m5C modification of SREBP2 mRNA. J Exp Clin Cancer Res. 2025 Jul 26;44(1):220. PMID: 40713894", "BibTeX": "@article{40713894, title={Copy number amplification of TTPAL promotes cholesterol biosynthesis and esophageal squamous cell carcinoma progression via elevating NSUN2-mediated m5C modification of SREBP2 mRNA.}, author={Huang S and Liu Y and Zhao M and Wang T and Mao L and Wang T and Guo C and Huang W and Peng Z and Zhang Z and Jiang R and Ma X and Shen N and Rao J and Wang X and Zheng Z and Chen L}, journal={J Exp Clin Cancer Res}, volume={44}, number={1}, pages={220}}"}}, {"_id": "37085031", "pmid": 37085031, "title": "Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.", "journal": "J Thorac Oncol", "authors": ["Chen WM", "Yu YH", "Chen M", "Shia BC", "Wu SY"], "date": "2023-04-20T00:00:00Z", "doi": "10.1016/j.jtho.2023.04.005", "meta_date_publication": "2023 Apr 20", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.14, "text_hl": "In addition, we found that use of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was associated with better survival outcomes for @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@ receiving CCRT. ", "citations": {"NLM": "Chen WM, Yu YH, Chen M, Shia BC, Wu SY. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study. J Thorac Oncol. 2023 Apr 20;():. PMID: 37085031", "BibTeX": "@article{37085031, title={Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.}, author={Chen WM and Yu YH and Chen M and Shia BC and Wu SY}, journal={J Thorac Oncol}}"}}, {"_id": "30579354", "pmid": 30579354, "pmcid": "PMC6303879", "title": "Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study", "journal": "Lipids Health Dis", "authors": ["Chen Y", "Li LB", "Zhang J", "Tang DP", "Wei JJ", "Zhuang ZH"], "date": "2018-12-22T00:00:00Z", "doi": "10.1186/s12944-018-0946-7", "meta_date_publication": "2018 Dec 22", "meta_volume": "17", "meta_issue": "1", "meta_pages": "290", "score": 50065.438, "text_hl": "@DISEASE_Adenocarcinoma @DISEASE_MESH:D000230 @@@Esophageal adenocarcinoma@@@ @CELLLINE_CVCL:1622 @@@OE-19@@@ cells and @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinoma@@@ @CELLLINE_CVCL:6898 @@@Eca-109@@@ cells were treated with different concentrations of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ for 24 h and 48 h. ", "citations": {"NLM": "Chen Y, Li LB, Zhang J, Tang DP, Wei JJ, Zhuang ZH. Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study Lipids Health Dis. 2018 Dec 22;17(1):290. PMID: 30579354", "BibTeX": "@article{30579354, title={Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study}, author={Chen Y and Li LB and Zhang J and Tang DP and Wei JJ and Zhuang ZH}, journal={Lipids Health Dis}, volume={17}, number={1}, pages={290}}"}}]}